Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Antimetastatic Effect of Fucoidan-Sargassum against Liver Cancer Cell Invadopodia Formation via Targeting Integrin αVβ3 and Mediating αVβ3/Src/E2F1 Signaling.

Pan TJ, Li LX, Zhang JW, Yang ZS, Shi DM, Yang YK, Wu WZ.

J Cancer. 2019 Aug 27;10(20):4777-4792. doi: 10.7150/jca.26740. eCollection 2019.

2.
3.

Metformin and Docosahexaenoic Acid Hybrid Micelles for Premetastatic Niche Modulation and Tumor Metastasis Suppression.

Jiang T, Chen L, Huang Y, Wang J, Xu M, Zhou S, Gu X, Chen Y, Liang K, Pei Y, Song Q, Liu S, Ma F, Lu H, Gao X, Chen J.

Nano Lett. 2019 Jun 12;19(6):3548-3562. doi: 10.1021/acs.nanolett.9b00495. Epub 2019 Apr 30.

PMID:
31026397
4.

Inhalable Fucoidan Microparticles Combining Two Antitubercular Drugs with Potential Application in Pulmonary Tuberculosis Therapy.

Cunha L, Rodrigues S, Rosa da Costa AM, Faleiro ML, Buttini F, Grenha A.

Polymers (Basel). 2018 Jun 8;10(6). pii: E636. doi: 10.3390/polym10060636.

5.

Microwave Responsive Nanoplatform via P-Selectin Mediated Drug Delivery for Treatment of Hepatocellular Carcinoma with Distant Metastasis.

Xu J, Cheng X, Tan L, Fu C, Ahmed M, Tian J, Dou J, Zhou Q, Ren X, Wu Q, Tang S, Zhou H, Meng X, Yu J, Liang P.

Nano Lett. 2019 May 8;19(5):2914-2927. doi: 10.1021/acs.nanolett.8b05202. Epub 2019 Apr 19.

PMID:
30929452
6.

Smooth Muscle Cells: A Novel Site of P-Selectin Expression with Pathophysiological and Therapeutic Relevance in Pulmonary Hypertension.

Sundd P, Kuebler WM.

Am J Respir Crit Care Med. 2019 Jun 1;199(11):1307-1309. doi: 10.1164/rccm.201812-2242ED. No abstract available.

7.

Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.

Novoyatleva T, Kojonazarov B, Owczarek A, Veeroju S, Rai N, Henneke I, Böhm M, Grimminger F, Ghofrani HA, Seeger W, Weissmann N, Schermuly RT.

Am J Respir Crit Care Med. 2019 Jun 1;199(11):1407-1420. doi: 10.1164/rccm.201806-1170OC.

PMID:
30557519
8.

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues.

Yu HH, Chengchuan Ko E, Chang CL, Yuan KS, Wu ATH, Shan YS, Wu SY.

Mar Drugs. 2018 Oct 19;16(10). pii: E392. doi: 10.3390/md16100392.

9.

Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs.

Cunha L, Rosa da Costa AM, Lourenço JP, Buttini F, Grenha A.

J Microencapsul. 2018 Jun;35(4):392-405. doi: 10.1080/02652048.2018.1513089.

PMID:
30112917
10.

PM2.5 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations.

Li KL, Lin YC.

Oncotarget. 2018 Jul 20;9(56):30748-30760. doi: 10.18632/oncotarget.25479. eCollection 2018 Jul 20.

11.

Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells.

Hsu HY, Lin TY, Hu CH, Shu DTF, Lu MK.

Cancer Lett. 2018 Sep 28;432:112-120. doi: 10.1016/j.canlet.2018.05.006. Epub 2018 May 8.

PMID:
29746926
12.

Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.

Kim IH, Nam TJ.

Oncol Rep. 2018 Mar;39(3):1516-1522. doi: 10.3892/or.2018.6193. Epub 2018 Jan 4.

PMID:
29328495
13.

Protective effects of fucoidan against hyperoxic lung injury via the ERK signaling pathway.

Nie M, Wang Y, Lu Y, Yuan Y, Liu Y, Li X.

Mol Med Rep. 2018 Jan;17(1):1813-1818. doi: 10.3892/mmr.2017.8022. Epub 2017 Nov 10.

PMID:
29138816
14.
15.

Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.

Chen H, Cong Q, Du Z, Liao W, Zhang L, Yao Y, Ding K.

Cancer Lett. 2016 Nov 1;382(1):44-52. doi: 10.1016/j.canlet.2016.08.020. Epub 2016 Aug 26.

PMID:
27569654
16.

Effect of fucoidan from Turbinaria conoides on human lung adenocarcinoma epithelial (A549) cells.

Alwarsamy M, Gooneratne R, Ravichandran R.

Carbohydr Polym. 2016 Nov 5;152:207-213. doi: 10.1016/j.carbpol.2016.06.112. Epub 2016 Jul 7.

PMID:
27516266
17.

P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.

Shamay Y, Elkabets M, Li H, Shah J, Brook S, Wang F, Adler K, Baut E, Scaltriti M, Jena PV, Gardner EE, Poirier JT, Rudin CM, Baselga J, Haimovitz-Friedman A, Heller DA.

Sci Transl Med. 2016 Jun 29;8(345):345ra87. doi: 10.1126/scitranslmed.aaf7374.

18.

The Oligo Fucoidan Inhibits Platelet-Derived Growth Factor-Stimulated Proliferation of Airway Smooth Muscle Cells.

Yang CH, Tsao CF, Ko WS, Chiou YL.

Mar Drugs. 2016 Jan 9;14(1):15. doi: 10.3390/md14010015.

19.

Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice.

Huang TH, Chiu YH, Chan YL, Chiu YH, Wang H, Huang KC, Li TL, Hsu KH, Wu CJ.

Mar Drugs. 2015 Apr 3;13(4):1882-900. doi: 10.3390/md13041882.

20.

Supplemental Content

Loading ...
Support Center